/PRNewswire/ Inhalis Therapeutics SA, a pioneering privately-held company specializing in advanced inhaled treatments for life-threatening diseases, proudly.
AdAlta Limited , the clinical stage drug discovery company developing novel therapeutic products from its i-body platform, today announced that its CEO and Managing Director, Dr Tim Oldham, would be. -Today at 07:35 am- MarketScreener
CBS 6 reported on the story of Sam Kirton, a man who eventually received a lung transplant after being diagnosed with pulmonary fibrosis, and given only two to five years to live.
The Investor Summit: AdAlta to Present at August 24th Virtual Investor Summit finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Galecto will stop developing its therapy for a disease that causes lung scarring after it failed to meet the main goal of a midstage study, the drug developer said on Tuesday.